The ANKS6 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the ANKS6 gene in the HeLa cervical adenocarcinoma epithelial cell line. This gene-edited model enables loss-of-function studies of ANKS6, a critical ciliary transition zone protein, within a widely used human cancer cell context. The polyclonal format provides a heterogeneous knockout pool, offering researchers a robust tool for investigating ciliogenesis and signaling pathways without the clonal selection artifacts of single-cell-derived lines. The product is supplied as a viable, proliferating population suitable for direct culture expansion and downstream functional assays. Users should confirm target-gene disruption through appropriate validation techniques such as western blotting or genomic sequencing, as the polyclonal nature does not guarantee complete knockout uniformity.
HeLa cells are an HPV-18-positive cervical adenocarcinoma-derived line, serving as a classic model for epithelial carcinoma and cancer biology. Their robust proliferation, ease of transfection, and well-characterized proteome make them ideal for gene-editing applications. In this system, ANKS6 knockout provides a platform to dissect ciliary and signaling mechanisms in a transformed epithelial background, complementing studies in primary or non-cancerous ciliated models. The HeLa context is particularly valuable for examining links between ciliopathy-associated proteins and oncogenic processes, given that many ciliary genes exhibit altered expression in cancers.
ANKS6 functions as a component of the ciliary transition zone, a gatekeeper region that controls protein entry and exit from the primary cilium. It interacts with key ciliopathy proteins including NPHP1, NPHP4, NPHP8, and inversin (INVS), forming complexes essential for ciliary membrane organization and trafficking. ANKS6 is required for proper Hedgehog signaling, operating downstream of the SHH ligand and the transmembrane regulator SMO to enable GLI transcription factor activation. Its disruption impairs the localization and function of the BBSome and IFT-A/IFT-B intraflagellar transport complexes, ultimately blocking transcriptional responses mediated by GLI1 and PTCH1. This molecular network links ANKS6 to both canonical and non-canonical Hedgehog pathways, as well as crosstalk with Wnt signaling, positioning it as a nodal regulator of ciliary-dependent signal transduction.
In HeLa cells, which retain a primary cilium under serum starvation conditions, ANKS6 knockout offers a unique model to study how ciliary transition zone defects influence cancer cell behavior. The loss of ANKS6 disrupts cilia architecture and impairs Hedgehog-dependent gene expression, potentially altering proliferation, migration, and invasive properties relevant to epithelial tumor progression. This model facilitates dissection of ciliopathy gene functions in a malignant epithelial setting, distinct from the renal cystic disease contexts typically associated with ANKS6 mutations. By combining the genetic tractability of HeLa cells with targeted gene disruption, researchers can explore the intersection of cilia biology and cancer signaling without the complexity of animal models or primary ciliated tissues.
Typical applications include screening for Hedgehog pathway modulators using GLI reporter assays or RT-qPCR for GLI target genes, investigating primary cilia formation and maintenance through immunofluorescence for acetylated tubulin and Arl13b, and assessing epithelial cell migration and invasion in the context of ciliary dysfunction. The polyclonal population also supports functional rescue experiments and interaction studies with NPHP complex members. This model is well-suited for drug discovery efforts targeting ciliopathies such as nephronophthisis and autosomal recessive polycystic kidney disease, as well as for probing ciliary contributions to Wnt signaling crosstalk. For further technical details, assay optimization, or customized cell product inquiries, please contact Ascent Research.
